{"schema_version":"secwatch.filing_event.v1","accession":"0001837607-24-000026","form_type":"8-K","ticker":"AEON","cik":"0001837607","company_name":"AEON Biopharma, Inc.","filed_at":"2024-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.610879+00:00","generated_at":"2026-06-03T23:05:03.303918+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AEON Biopharma sets warrant redemption FMV at $7.6994, cashless ratio 0.2456","bullets":["Redemption Fair Market Value calculated at $7.6994 per Public Warrant under Warrant Agreement Section 6.2.","Cashless exercise yields approximately 0.2456 shares of common stock per Public Warrant.","Redemption date remains April 29, 2024; unexercised warrants void and holders receive $0.10 each.","Supplemental notice follows initial redemption announcement on March 29, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001837607-24-000026","json":"https://secwatch.observer/filing/0001837607-24-000026.json","markdown":"https://secwatch.observer/filing/0001837607-24-000026.md","text":"https://secwatch.observer/filing/0001837607-24-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1837607/000183760724000026/0001837607-24-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1837607/000183760724000026/aeon-20240415x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T23:05:03.303918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}